---
$id: https://graph.org.ai/products/commodity/51111769
$type: Product
source: UNSPSC
code: "51111769"
title: "Vinflunine"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vinflunine

**UNSPSC Code**: 51111769
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C45H54F2N4O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5BF646324K, chemically known as 4-deoxy-20,20-difluoro-c-norvincaleukoblastine but generally known as vinflunine, which bears US NIH Compound Identifier 157688. European Medicines Agency schedules Vinflunine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00063MIG. The term VINFLUNINE is an International Non-Proprietary Name. World Health Organization schedules vinflunine in its Anatomical Therapeutic Chemical (ATC) Classification. VINFLUNINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vinflunine under HS 29399900 and SITC 54149. As of Q4 2014, VINFLUNINE remains the US FDA Preferred Term for this commodity. Vinflunine bears US NLM identifiers UMLS ID C0672663 and NCI Concept Code C61564. SMILES: FC(F)(C1CC2CC(C3CC4C56C7N(CC6)CC=CC7(C(OC(=O)C)C(O)(C5N(C4CC3OC)C)C(=O)OC)CC)(C3[NH]C4C(C3CN(C2)C1)CCCC4)C(=O)OC)C.

